Global Healthcare Contract Development & Manufacturing Organization Market Research Report (2021 to 2026) - by Services, End-user and Region

Dublin, IRELAND


Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "Healthcare Contract Development & Manufacturing Organization Market Research Report by Services, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Healthcare Contract Development & Manufacturing Organization Market size was estimated at USD 219.63 billion in 2020 and expected to reach USD 247.78 billion in 2021, at a CAGR 13.15% to reach USD 461.12 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Healthcare Contract Development & Manufacturing Organization to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Services, the market was studied across Clinical, Contract Development, Contract Manufacturing, and Laboratory Services. The Clinical is further studied across Phase I, Phase II, Phase III, and Phase IV. The Contract Development is further studied across Preclinical. The Preclinical is further studied across Bioanalysis and DMPK studies and Toxicology Testing. The Contract Manufacturing is further studied across API/Bulk Drugs, Finished Dose Formulations, and Medical Device. The Medical Device is further studied across Class I, Class II, and Class III. The Laboratory Services is further studied across Analytical Services and Bioanalytical Services.
  • Based on End-User, the market was studied across Big Pharmaceutical Companies, Generic Pharmaceutical Companies, and Small & Medium-Sized Pharmaceutical Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Healthcare Contract Development & Manufacturing Organization Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Healthcare Contract Development & Manufacturing Organization Market, including Catalent Inc., Covance Inc., Flex, IQVIA Holdings Inc., Jabil, Lonza Group Ltd., Recipharm AB, Sanmina Corporation, Siegfried Holding AG, and Thermo Fisher Scientific Inc.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Healthcare Contract Development & Manufacturing Organization Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Healthcare Contract Development & Manufacturing Organization Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Healthcare Contract Development & Manufacturing Organization Market?
4. What is the competitive strategic window for opportunities in the Global Healthcare Contract Development & Manufacturing Organization Market?
5. What are the technology trends and regulatory frameworks in the Global Healthcare Contract Development & Manufacturing Organization Market?
6. What is the market share of the leading vendors in the Global Healthcare Contract Development & Manufacturing Organization Market?
7. What modes and strategic moves are considered suitable for entering the Global Healthcare Contract Development & Manufacturing Organization Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Increasing outsourcing services by pharmaceutical companies
5.2.2. Patent expiry and increasing demand for generic drugs
5.2.3. Increasing demand for one-stop-shop contract development & manufacturing organization
5.3. Restraints
5.3.1. Compliance issues while outsourcing and regulatory and legal compliance
5.4. Opportunities
5.4.1. Increasing investment in pharmaceutical research & development
5.4.2. Increasing demand for biological therapies
5.5. Challenges
5.5.1. Capacity utilization issues affecting the profitability of contract development & manufacturing organization

6. Healthcare Contract Development & Manufacturing Organization Market, by Services
6.1. Introduction
6.2. Clinical
6.2.1. Phase I
6.2.2. Phase II
6.2.3. Phase III
6.2.4. Phase IV
6.3. Contract Development
6.3.1. Preclinical
6.3.1.1. Bioanalysis and DMPK studies
6.3.1.2. Toxicology Testing
6.4. Contract Manufacturing
6.4.1. API/Bulk Drugs
6.4.2. Finished Dose Formulations
6.4.3. Medical Device
6.4.3.1. Class I
6.4.3.2. Class II
6.4.3.3. Class III
6.5. Laboratory Services
6.5.1. Analytical Services
6.5.2. Bioanalytical Services

7. Healthcare Contract Development & Manufacturing Organization Market, by End-User
7.1. Introduction
7.2. Big Pharmaceutical Companies
7.3. Generic Pharmaceutical Companies
7.4. Small & Medium-Sized Pharmaceutical Companies

8. Americas Healthcare Contract Development & Manufacturing Organization Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Healthcare Contract Development & Manufacturing Organization Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand

10. Europe, Middle East & Africa Healthcare Contract Development & Manufacturing Organization Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Catalent Inc.
12.2. Covance Inc.
12.3. Flex
12.4. IQVIA Holdings Inc.
12.5. Jabil
12.6. Lonza Group Ltd.
12.7. Recipharm AB
12.8. Sanmina Corporation
12.9. Siegfried Holding AG
12.10. Thermo Fisher Scientific Inc.

13. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/v1k6wy

 

Coordonnées